首页> 外文期刊>Knee surgery, sports traumatology, arthroscopy: official journal of the ESSKA >Biodegradable polyurethane meniscal scaffold for isolated partial lesions or as combined procedure for knees with multiple comorbidities: Clinical results at 2 years
【24h】

Biodegradable polyurethane meniscal scaffold for isolated partial lesions or as combined procedure for knees with multiple comorbidities: Clinical results at 2 years

机译:可生物降解的聚氨酯半月板支架,用于孤立的部分病变或合并合并多种疾病的膝盖:2年的临床结果

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose: The aim of this study is to evaluate the safety and clinical efficacy of this novel polyurethane meniscal scaffold to treat partial meniscal loss. Methods: Eighteen patients (11 men and 7 women, mean age: 45 years) affected by irreparable acute meniscal tears requiring partial meniscectomy or chronic prior loss of meniscal tissue were enrolled in the study. They underwent arthroscopic polyurethane meniscal scaffold implantation (13 medial and 5 lateral) and, in case of presence of other comorbidities, concurrent procedures were also performed. Patients were prospectively evaluated up to 2 years of follow-up through IKDC objective, IKDC subjective, and Tegner scores. Furthermore, MRI evaluation of the meniscal scaffold was performed. Results: No major adverse events were observed. A statistically significant increase in all the clinical parameters considered was found. The IKDC objective score increased from 61 % of normal or nearly normal knees at basal evaluation to 94 % at 2 years of follow-up (p = 0.01). There was also a significant increase in the IKDC subjective score both at 6-12 months of follow-up (p = 0.03 and p < 0.005), which was confirmed at 24 months. The Tegner score also showed a significant increase from the pre-operative level (median value 2, range 1-5) to final evaluation (median value 3, range 2-5; p = 0.005), albeit not reaching the pre-injury sports activity level. Conclusions: The implantation of this novel polyurethane scaffold proved to be a safe and potentially effective procedure to treat partial meniscal loss with encouraging results at short-term follow-up. Further high-quality studies with larger numbers of patients and longer evaluation times are needed to confirm these preliminary data. Level of evidence: Case series, Level IV.
机译:目的:本研究的目的是评估这种新型聚氨酯半月板支架治疗部分半月板丢失的安全性和临床疗效。方法:本研究纳入了18例因无法修复的急性半月板撕裂而需要部分半月板切除术或慢性半月板组织丧失的患者(11名男性和7名女性,平均年龄:45岁)。他们进行了关节镜下的聚氨酯半月板支架植入术(内侧13处,外侧5处),并且在存在其他合并症的情况下,还进行了同时手术。通过IKDC客观,IKDC主观评分和Tegner评分对患者进行长达2年的随访。此外,对半月板支架进行了MRI评估。结果:未观察到重大不良事件。发现所考虑的所有临床参数在统计学上均显着增加。 IKDC客观评分从基础评估时的正常或接近正常膝关节的61%增加到随访2年的94%(p = 0.01)。随访6-12个月,IKDC主观评分均显着增加(p = 0.03和p <0.005),这一点在24个月时得到确认。 Tegner评分也显示从术前水平(中值2,范围1-5)到最终评估(中值3,范围2-5; p = 0.005)有显着提高,尽管未​​达到损伤前运动水平活动水平。结论:植入这种新型聚氨酯支架被证明是治疗部分半月板丢失的安全且潜在有效的方法,短期随访结果令人鼓舞。需要进一步的高质量研究,包括更多的患者和更长的评估时间,以确认这些初步数据。证据级别:案例系列,IV级。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号